Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Lymphoma and AICDA[original query] |
---|
BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab. American journal of hematology 2017 Jun 92 (6): 515-519. Huet Sarah, Szafer-Glusman Edith, Tesson Bruno, Xerri Luc, Fairbrother Wayne J, Mukhyala Kiran, Bolen Chris, Punnoose Elizabeth, Tonon Laurie, Chassagne-Clément Catherine, Feugier Pierre, Viari Alain, Jardin Fabrice, Salles Gilles, Sujobert Pier |
Subclonal TP53 mutation are frequent and predict resistance to radio-immunotherapy in follicular lymphoma. Blood advances 2023 6 . W Richard Burack, Hongli Li, Diana G Adlowitz, Janice M Spence, Lisa M Rimsza, Mazyar Shadman, Catherine Spier, Mark S Kaminski, John P Leonard, Michael Leblanc, Sonali M Smith, Jonathan W Friedbe |
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era. Blood cancer journal 2023 5 13 (1): 81. Cristina Correia, Matthew J Maurer, Samantha J McDonough, Paula A Schneider, Paige E Ross, Anne J Novak, Andrew L Feldman, James R Cerhan, Susan L Slager, Thomas E Witzig, Bruce W Eckloff, Hu Li, Grzegorz S Nowakowski, Scott H Kaufma |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: